{
  "docId": "019de076-2049-75e8-9528-894c783c20b2",
  "docSlug": "1f0c6538bd85906c2fdac9c48c149895",
  "documentTitle": "argenx SE | Investor Presentation Deck | 25 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 25,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Clinical trial design schematic showing randomization, screening criteria, and study endpoints.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-2049-75e8-9528-894c783c20b2/22",
  "deckHref": "/decks/019de076-2049-75e8-9528-894c783c20b2",
  "deckJsonHref": "/decks/019de076-2049-75e8-9528-894c783c20b2.json",
  "deckAnchorHref": "/decks/019de076-2049-75e8-9528-894c783c20b2#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.23,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "Randomization (2:1) between Efgartigimod and Placebo",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8f551a6-9c43-4f5e-bd4f-c86fd29c1669",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.82,
        "y": 0.02
      },
      "kind": "image",
      "text": "alpha STUDY",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "147b5520-9076-4287-a0c5-34b484bdc514",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.71,
        "y": 0.3
      },
      "kind": "list",
      "text": "Co-primary and secondary endpoints including MALMO POTS, COMPASS, PROMIS, and PGI-S/C",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32ede543-edf4-4e42-99aa-b0bf7b881ee1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.04,
        "y": 0.3
      },
      "kind": "list",
      "text": "Screening Criteria: Prior COVID-19, sustained HR increase, vasomotor/sympathetic symptoms, COMPASS score",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ed8040d-d861-40a0-9683-5f1cd8879135",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.25,
        "y": 0.78
      },
      "kind": "metric",
      "text": "Topline data expected 1Q 2024",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a1d885b-f889-4f86-814a-40aec3d6ac48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.28,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "PC-POTS ALPHA Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9406468-991d-4505-9f6d-33e9a63bb9aa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}